Clinical Trials Browser

Phase 3 × Has results × Colorectal Neoplasms × Clear all

NCT02647099 2026-03-13

ALASCCA

Phase 3 Active not recruiting

626 enrolled 14 charts

Gastrointestinal

Colorectal Neoplasms

NCT03362177 2026-02-11

RECITE

Phase 3 Completed

165 enrolled 22 charts

Gastrointestinal

Gastrointestinal Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms

NCT04776148 2026-02-05

MK-7902-017

Phase 3 Completed

563 enrolled 32 charts

Gastrointestinal

Parkinson Disease 4, Autosomal Dominant Lewy Body, Colorectal Neoplasms

NCT04457297 2026-01-21

ALTAIR

Phase 3 Completed

243 enrolled 13 charts

Gastrointestinal

Digestive System Diseases, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Colorectal Neoplasms

NCT05600309 2025-11-26

A Study of Coformulated Favezelimab/Pembrolizumab (MK-4280A) Versus Standard of Care in Subjects With Previously Treated Metastatic PD-L1 Positive Colorectal Cancer (MK-4280A-007)-China Extension Study

Phase 3 Completed

94 enrolled 15 charts

Gastrointestinal

Parkinson Disease 4, Autosomal Dominant Lewy Body, Colorectal Neoplasms

NCT03829462 2025-11-21

NEXT-REGIRI

Phase 3 Active not recruiting

377 enrolled 30 charts

Gastrointestinal

Colorectal Neoplasms

NCT04008030 2025-10-03

CheckMate 8HW

Phase 3 Active not recruiting

839 enrolled 22 charts 3 FDA

Gastrointestinal

Colorectal Neoplasms

NCT05064059 2025-09-17

MK-4280A-007

Phase 3 Completed

441 enrolled 24 charts

Gastrointestinal

Parkinson Disease 4, Autosomal Dominant Lewy Body, Colorectal Neoplasms

NCT04322539 2025-04-04

FRESCO-2

Phase 3 Completed

691 enrolled 26 charts 2 FDA

Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT04607668 2024-11-26

PRESERVE1

Phase 3 Terminated

326 enrolled 15 charts

Gastrointestinal

Colorectal Neoplasms

NCT04456699 2024-10-29

LYNK-003

Phase 3 Completed

335 enrolled 19 charts

Gastrointestinal

Colorectal Neoplasms

NCT02563002 2024-10-03

KEYNOTE-177

Phase 3 Completed

307 enrolled 16 charts 3 FDA

Gastrointestinal

Parkinson Disease 4, Autosomal Dominant Lewy Body, Colorectal Neoplasms

NCT04737187 2024-09-24

SUNLIGHT

Phase 3 Completed

492 enrolled 22 charts 2 FDA

Gastrointestinal

Colorectal Neoplasms

NCT01607957 2024-09-19

RECOURSE

Phase 3 Completed

800 enrolled 12 charts

Gastrointestinal

Colorectal Neoplasms

NCT05223673 2024-08-20

COLSTAR

Phase 3 Terminated

7 enrolled 12 charts

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

NCT02928224 2023-12-21

BEACON CRC

Phase 3 Completed

702 enrolled 82 charts 3 FDA

Gastrointestinal

Colorectal Neoplasms

NCT02753127 2023-11-15

CanStem303C

Phase 3 Completed

1,253 enrolled 18 charts

Gastrointestinal

Colonic Diseases, Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Intestinal Diseases, Intestinal Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial, Rectal Diseases, Colorectal Neoplasms

NCT02394795 2023-11-01

PARADIGM

Phase 3 Completed

823 enrolled 20 charts

Gastrointestinal

Colorectal Neoplasms

NCT01830621 2023-08-28

BBI608 and Best Supportive Care vs Placebo and Best Supportive Care in Pretreated Advanced Colorectal Carcinoma

Phase 3 Completed

282 enrolled 15 charts

Gastrointestinal

Colorectal Neoplasms

NCT01011478 2023-08-16

Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery

Phase 3 Terminated

406 enrolled 14 charts

GastrointestinalOther neoplasm

Colonic Neoplasms, Precancerous Conditions, Colorectal Neoplasms, Adenomatous Polyps

NCT00002525 2023-06-28

Perioperative Chemotherapy in Treating Patients With Colon Cancer That Can Be Surgically Removed

Phase 3 Terminated

859 enrolled 8 charts

Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT01718873 2023-04-12

OBELICS

Phase 3 Completed

230 enrolled 12 charts

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

NCT00113763 2022-11-07

Evaluating Panitumumab (ABX-EGF) Plus Best Supportive Care Versus Best Supportive Care in Patients With Metastatic Colorectal Cancer

Phase 3 Completed

463 enrolled 17 charts

Gastrointestinal

Neoplasm Metastasis, Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00364013 2022-11-07

PRIME: Panitumumab Randomized Trial In Combination With Chemotherapy for Metastatic Colorectal Cancer to Determine Efficacy

Phase 3 Completed

1,183 enrolled 18 charts

Gastrointestinal

Neoplasms, Colorectal Neoplasms

NCT01099449 2022-11-03

Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy

Phase 3 Completed

362 enrolled 17 charts

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms, Neurotoxicity Syndromes

NCT00339183 2022-09-23

Comparison of Treatment Effect of Chemotherapy With Panitumumab to Chemotherapy Alone

Phase 3 Completed

1,186 enrolled 18 charts

Gastrointestinal

Neoplasms, Colorectal Neoplasms

NCT01001377 2022-09-21

ASPECCT: A Study of Panitumumab Efficacy and Safety Compared to Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal Cancer

Phase 3 Completed

1,010 enrolled 22 charts

Gastrointestinal

Colonic Neoplasms, Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms

NCT01150045 2022-03-22

Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery

Phase 3 Unknown

2,527 enrolled 14 charts

Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT04034355 2022-01-26

POLAR-A

Phase 3 Terminated

301 enrolled 18 charts

Gastrointestinal

Neoplasms, Peripheral Nervous System Diseases, Colorectal Neoplasms

NCT03654729 2021-12-17

POLAR-M

Phase 3 Terminated

291 enrolled 20 charts

Gastrointestinal

Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms

NCT02231086 2021-09-16

COLOPEC

Phase 3 Completed

204 enrolled 7 charts

GastrointestinalGynecologic

Peritoneal Neoplasms, Colorectal Neoplasms

NCT01767857 2021-06-29

XCITE

Phase 3 Terminated

643 enrolled 16 charts

Gastrointestinal

Colorectal Neoplasms

NCT03288987 2021-01-22

Comparing Efficacy and Safety of Stivant (AryoGen Bevacizumab) Versus Avastin in Metastatic Colorectal Cancer

Phase 3 Completed

126 enrolled 15 charts

Gastrointestinal

Colorectal Neoplasms

NCT01955837 2020-11-17

TERRA

Phase 3 Completed

406 enrolled 22 charts

Gastrointestinal

Colorectal Neoplasms

NCT00265850 2020-05-07

Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer

Phase 3 Completed

2,334 enrolled 9 charts

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00726622 2020-05-07

Laparoscopic-Assisted Resection or Open Resection in Treating Patients With Rectal Cancer

Phase 3 Completed

486 enrolled 13 charts

Gastrointestinal

Rectal Neoplasms, Colorectal Neoplasms

NCT00069121 2020-03-06

A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer

Phase 3 Completed

1,886 enrolled 16 charts

Gastrointestinal

Colorectal Neoplasms

NCT01228734 2020-01-28

TAILOR

Phase 3 Completed

553 enrolled 13 charts

Gastrointestinal

Colorectal Neoplasms

NCT00706121 2019-12-16

ACP

Phase 3 Completed

8,094 enrolled 23 charts

GastrointestinalOther neoplasm

Colonic Neoplasms, Precancerous Conditions, Rectal Neoplasms, Colorectal Neoplasms, Adenomatous Polyps

NCT02788279 2019-12-11

A Study to Investigate Efficacy and Safety of Cobimetinib Plus Atezolizumab and Atezolizumab Monotherapy Versus Regorafenib in Participants With Metastatic Colorectal Adenocarcinoma (COTEZO IMblaze370)

Phase 3 Completed

363 enrolled 19 charts

Gastrointestinal

Colorectal Neoplasms

NCT02776683 2019-11-21

INVICTAN®-3

Phase 3 Completed

123 enrolled 14 charts

Gastrointestinal

Colorectal Neoplasms

NCT01721954 2019-11-05

FOXFIREGlobal

Phase 3 Completed

209 enrolled 16 charts

Gastrointestinal

Colorectal Neoplasms

NCT01183780 2019-09-25

A Study in Second Line Metastatic Colorectal Cancer

Phase 3 Completed

1,072 enrolled 17 charts

Gastrointestinal

Colorectal Neoplasms

NCT00078897 2019-09-24

Selenium for Prevention of Adenomatous Colorectal Polyps

Phase 3 Terminated

1,621 enrolled 12 charts

GastrointestinalOther neoplasm

Colonic Neoplasms, Precancerous Conditions, Rectal Neoplasms, Colorectal Neoplasms, Adenomatous Polyps

NCT00252564 2019-02-15

Cetuximab, Bevacizumab & 5FU/Leucovorin vs. Oxaliplatin, Bevacizumab & 5FU/Leucovorin in Metastatic Colorectal Cancer

Phase 3 Completed

247 enrolled 12 charts

Gastrointestinal

Colorectal Neoplasms

NCT00115765 2018-10-17

PACCE: Panitumumab Advanced Colorectal Cancer Evaluation Study

Phase 3 Completed

1,053 enrolled 25 charts

Gastrointestinal

Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT02254486 2018-05-15

NOCT

Phase 3 Completed

621 enrolled 13 charts

Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT02273141 2018-05-15

Multicenter Randomized Parallel Group Phase III Study Comparing the Bowel Cleansing Efficacy, Safety and Tolerability of NER1006 Versus a Sodium Picosulfate and Magnesium Salt Solution Using Day Before-Only Dosing Regimen in Adults.

Phase 3 Completed

515 enrolled 13 charts

Gastrointestinal

Colorectal Neoplasms

NCT02273167 2018-05-15

MORA

Phase 3 Completed

849 enrolled 14 charts

Gastrointestinal

Colorectal Neoplasms

NCT00601172 2018-01-17

A Study Of IV Casopitant For The Prevention Of Chemotherapy Induced Nausea And Vomiting.

Phase 3 Completed

710 enrolled 29 charts

Gastrointestinal

Nausea, Vomiting, Colorectal Neoplasms